This proposed research is focused on better understanding and tackling triple-negative breast cancer (TNBC), for which currently no molecularly targeted therapeutic strategies are available. We will combine state-of-the-art preclinical experimental model systems and powerful bioinformatics approaches to identify ways to induce cell death selectively in triple-negative tumor cells while sparing non-tumorigenic cells.
|Effective start/end date||4/1/15 → 3/31/18|
- National Cancer Institute (5R00CA175700-05)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.